WELCOME TO PARI PHARMA!

The future of effective aerosol therapies lies in the optimization of drug-to-device and device-to-drug. PARI Pharma has taken the next step and combined formulation development, next generation aerosol platforms, and aerosol characterization under one roof.

We are currently working with both the eFlow Technology (lower respiratory) and Vibrent Technology (upper respiratory) Advanced Aerosol Delivery platforms.

This multifunctional development program is the key to creating targeted therapies with high deposition amounts, low side-effect profiles, improved patient compliance…and better controlled, healthier patients.

After 100 years, we know aerosol science and aerosol delivery.

Friday, 18. June 2010

Partner Release: GILEAD’S HEAD-TO-HEAD STUDY OF CAYSTON® VERSUS TOBRAMYCIN INHALATION SOLUTION IN CYSTIC FIBROSIS PATIENTS ACHIEVES CO-PRIMARY EFFICACY ENDPOINT OF NON-INFERIORITY

Cayston Data Meet Statistical Definition of Superiority
Thursday, 17. June 2010

Partner Release: ARIKACETM DEMONSTRATES SUSTAINED BENEFIT IN THE TREATMENT OF CYSTIC FIBROSIS PATIENTS WHO HAVE PSEUDOMONAS LUNG INFECTIONS

Data Presented at the European Cystic Fibrosis Society Conference
Monday, 24. May 2010

Partner Release: We're pleased to share the following positive news from Transave re: a composition of matter patent for ARIKACE delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH)

TRANSAVE ISSUED KEY COMPOSITION OF MATTER PATENT FOR ARIKACE
Monday, 17. May 2010

Partner Release: Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of AeroquinTM (MP-376) Treatment in Cystic Fibrosis Patients

Data Presented at the American Thoracic Society Annual Meeting
Tuesday, 23. February 2010

PARI Pharma’s Altera Delivers Gilead’s Cayston, Approved by the U.S. FDA for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa

 

MONTEREY, CALIFORNIA – Altera, which uses eFlow Technology, was cleared to market today by the FDA as the first drug-specific nebulizer for use in the...